GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Debt-to-Revenue

CardioGenics Holdings (CardioGenics Holdings) Debt-to-Revenue : N/A (As of Jan. 2016)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

CardioGenics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2016 was $0.38 Mil. CardioGenics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2016 was $0.00 Mil. CardioGenics Holdings's annualized Revenue for the quarter that ended in Jan. 2016 was $0.00 Mil.


CardioGenics Holdings Debt-to-Revenue Historical Data

The historical data trend for CardioGenics Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Debt-to-Revenue Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.22 3.00 N/A N/A N/A

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of CardioGenics Holdings's Debt-to-Revenue

For the Diagnostics & Research subindustry, CardioGenics Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioGenics Holdings's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Debt-to-Revenue falls into.



CardioGenics Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

CardioGenics Holdings's Debt-to-Revenue for the fiscal year that ended in Oct. 2015 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.073 + 0) / N/A
=N/A

CardioGenics Holdings's annualized Debt-to-Revenue for the quarter that ended in Jan. 2016 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jan. 2016) Revenue data.


CardioGenics Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines